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Accumulating evidence suggests that the intrauterine envi-
ronment can have an impact on long-term offspring health, so-
called ‘fetal programming’. A number of environmental
stressors have been studied in humans including maternal
nutrition, smoking, substance misuse and mental illness.
Although various biological mechanisms are likely to underpin
fetal programming effects, there has been a particular focus on
epigenetic modifications as potential mediators of observed
associations between early environmental exposures and later
health outcomes. In this review, we give an overview of evi-
dence supporting a role for epigenetics in fetal programming,
highlighting key human and animal studies. We also discuss
challenges for research in this area, along with recommenda-
tions for future work, and potential therapeutic applications.
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Human and animal studies have demonstrated a link
between in utero fetal stressors and altered risk of adult
disease. Pioneering work in this field was conducted by
David Barker who linked low birthweight to increased
risk of metabolic disease and cardiovascular mortality in
adulthood [1,2]. A diverse range of exposures in preg-
nancy have since been linked to life-long health out-
comes in offspring including undernutrition andwww.sciencedirect.comovernutrition, maternal mental illness and substance
misuse [3e7].
Although the underlying mechanisms remain unclear, it
has been hypothesised that certain intrauterine
stressors may alter developmental trajectories in early
life to ensure the highest chance of fitness and/or sur-
vival in later life as part of an adaptive response [8].
Barker postulated that poor nutrition in pregnancy
caused physiological reprogramming resulting in an
offspring well adapted to poor nutrition. Such an indi-
vidual would then be at increased risk of metabolic
disease in a nutritionally rich environment, the so-called
‘thrifty phenotype’ hypothesis [9].
Epigenetic modifications to the genome involve mitot-
ically heritable changes that can influence gene
expression without changing the underlying DNA
sequence [10]. There is great interest in the potential
for epigenetic modifications to mediate observed links
between early environmental exposures and later health
outcomes because they can be sensitive to the peri-
conceptional and in utero environment and can persist
throughout development [11]. In this short review we
explore the role of epigenetic processes in mediating
fetal programming using evidence from animal and
human studies. We also highlight some of the challenges
of research in this field and describe its potential use for
identifying prognostic biomarkers and for designing
therapeutic interventions, as well as suggesting avenues
for future research.Fetal programming and epigenetics
Epigenetic modifications include DNA methylation,
histone modifications and RNA-based processes [10].
DNA methylation involves the addition of a methyl
group to a cytosine base, most commonly where the
cytosine is adjacent to a guanine, termed a ‘CpG’ site.
CpG methylation at gene promoters typically leads to
gene silencing although effects on transcription gener-
ally vary according to genomic context. Histone proteins
act to compress DNA by coiling it up into units called
‘nucleosomes’. Histone modifications including
methylation, acetylation and phosphorylation of histone
‘tails’ can influence gene expression by affecting the
accessibility of the DNA and its packaging into areas of
active and inactive transcription. There is increasing
evidence that DNA methylation and histoneCurrent Opinion in Endocrine and Metabolic Research 2020, 13:1–6
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regulate gene expression. Most research linking epige-
netic changes to fetal programming in humans have
focussed on DNA methylation due to its stability in
isolated DNA and to the availability of low-cost assays.
This epigenetic mark is therefore the focus of this
review.
DNA methylation plays a crucial role in embryonic and
fetal development, most notably in establishing and
maintaining cellular identity, in X-inactivation in
women and in the regulation of genomic imprinting
[12]. The first few days after conception constitute a
particularly dynamic phase of epigenetic reprogram-
ming, when epigenetic marks from parental gametes
are largely erased to render cells into a ‘naı̈ve’ state,
ready to acquire cell- and tissue-specific marks at
gastrulation and beyond [13]. This cascade of early
developmental processes which includes molecular
mechanisms that maintain parent of origin-specific
methylation at genomic imprints points to the peri-
conceptional period as a ‘critical window’ for epige-
netically mediated fetal programming effects. Indeed
many fetal programming studies focus on imprinted loci
as potential hotspots of environmental influence in the
human methylome [14].Interpreting DNA methylation association
signals
Multiple factors complicate the interpretation of re-
sults from epigenome-wide association studies [15]. In
a fetal programming context, this means that the
identification of a statistically significant association
between an early exposure and methylation at a
particular locus is only a first step. Relevant factors
include the extent (single CpG or regional, encom-
passing multiple CpG) and location (position with
respect to regulatory features such as promoters or
enhancers) of an association signal, both of which can
inform its likely functional significance. The difficulty
of assessing methylation changes in functionally rele-
vant tissues is another consideration when attempting
to assess functional relevance in human cohort studies.
The observed effect size may also be important
because, for example, large studies may be powered to
detect small methylation differences that may be
functionally unimportant. Ideally, exposure-related
methylation changes should be linked to gene
expression changes in functionally relevant tissues.
Where these are unavailable, reference to external
bioinformatics resources with expression and other
epigenetic data can help to inform functional signifi-
cance. Other considerations include the difficulty of
establishing causal links between exposure, methyl-
ation and phenotype. This and the potential use of
association signals as noncausal biomarkers of fetal
programming effects are considered in a later section.Current Opinion in Endocrine and Metabolic Research 2020, 13:1–6Animal studies
The ability to study mammalian development in rele-
vant tissues and in tightly controlled environments
means that animal studies have played an important part
in establishing the role of epigenetically driven fetal
programming in altering later disease risk. Studies in
rodents have shown that maternal undernutrition and
overnutrition, micronutrient status and stress can in-
fluence the physiology of the offspring, and that these
changes are often accompanied by changes in the
methylation of key metabolic or regulatory genes [16e
20]. For example, feeding rats a protein-restricted diet
during pregnancy induced hypomethylation of the
glucocorticoid receptor and peroxisomal proliferator-
activated receptor (Ppar)-a promoters in the livers of
juvenile and adult offspring, which was associated with
an increase in glucocorticoid receptor and Ppara mRNA
expression [21,22], whereas Vucetic et al. [19] showed
hypomethylation and increased expression of the m-
opioid receptor (Mor) and preproenkephalin (Penk) in
the nucleus accumbens, prefrontal cortex and hypo-
thalamus of mice from dams that consumed a high-fat
diet during pregnancy.
Animal studies can also help identify details of the
specific epigenetic mechanisms involved. Using a model
of intrauterine ligation, which results in intrauterine
growth restriction, Park et al. [23] found that the
decrease in the expression of the pancreatic and
duodenal homoeobox 1 (Pdx1) transcription factor was
accompanied by changes in histone modifications
around the pdx1 promoter which was subsequently
followed by a change in DNA methylation, suggesting
that DNA methylation may consolidate the change in
expression.Human studies
Early studies demonstrating a link between prenatal
environment and altered epigenetic profiles in offspring
were conducted in the offspring of mothers who were
pregnant during the ‘Dutch Hunger Winter’ (DHW)
[3,24]. This severe famine was caused by food shortages
in Northwestern Holland during the Second World War.
Initially, researchers noted that there was an increased
risk of obesity in young men whose mothers were
pregnant during the famine [3]. Further studies
demonstrated altered DNA methylation up to six de-
cades later, with the periconceptual and early pregnancy
period identified as a critical period for famine exposure
[24,25]. Methylation changes in blood were associated
with genes related to growth and increased risk of
metabolic disease in both male and female offspring
[26].
Maternal BMI
A number of studies have demonstrated associations
between maternal body mass index (BMI) and DNAwww.sciencedirect.com
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studies has identified links between maternal BMI and
methylation in placenta, cord blood and child saliva at
several genes with a known role in energy metabolism
including PPARG and leptin (LEP) [27e29]. The
advent of array-based platforms such as the Illumina
450 k and EPIC arrays has enabled the measurement of
methylation genome-wide, although coverage with
these arrays is still limited to 2e3% of CpGs in the
genome. Analysis of 450 k methylation data from the UK
Avon Longitudinal Study of Parents and Children
(ALSPAC) cohort demonstrated an association between
maternal BMI and altered offspring methylation at
several loci in cord blood, and in peripheral blood at 6
and 15 years of age [30]. Stronger associations with
maternal rather than paternal BMI supported an intra-
uterine mechanism, and methylation changes were
associated with differences in offspring adiposity. A
meta-analysis of >10,000 mothereoffspring pairs in the
Pregnancy and Childhood Epigenetics (PACE) con-
sortium found significant associations at large numbers
of loci in newborn blood, although most were accounted
for by changes in blood cell composition, with evidence
for a causal uterine effect at 8 loci. There was some
evidence for persistence of signals into adolescence
[31].
Children born after maternal bariatric surgery have
improved cardiovascular risk profiles compared with
their unexposed siblings, and a number of studies have
investigated potential epigenetic mediators. A sibling
study explored the impact of maternal bariatric surgery
on blood methylation levels of genes associated with
cardiometabolic pathways in offspring born before and
after maternal bariatric surgery and identified multiple
differentially methylated loci [32]. A similar study found
that maternal bariatric surgery is associated with
methylation differences at genes involved in glucose and
leptin signalling [33].
Maternal diabetes
DNA methylation changes in offspring have also been
associated with maternal diabetes with differential
methylation at some loci linked to metabolic changes in
offspring. One study in 485 motherechild dyads found
evidence that changes in cord blood methylation at the
leptin gene mediated the relationship between
maternal hyperglycaemia and neonatal leptin levels
[34]. A study of 388 Pima Indian children found sig-
nificant associations between exposure to intrauterine
maternal type two diabetes mellitus and DNA methyl-
ation in blood at multiple genes, some of which were
linked to impaired insulin secretion, weight gain and
increased risk of type 2 diabetes [35]. An analysis of
offspring from the US Exploring Perinatal Outcomes
among Children (EPOCH) cohort that were exposed to
gestational diabetes mellitus also found alterations inwww.sciencedirect.comblood methylation at a number of genes, one of which
was associated with multiple adiposity-related outcomes
[36]. A recent Danish study with more than 1200 cases
and controls also found associations between gestational
diabetes mellitus and blood methylation changes in
children, although most were confounded by maternal
BMI, and only one CpG was validated in a replication
cohort [37]. Results from array-based studies assessing
genome-wide methylation are generally inconsistent,
perhaps reflecting differences in inclusion criteria, time
of methylation measurement and adjustment covariates
used (e.g. maternal BMI).
Maternal nutrition
Nutrition can influence DNA methylation through the
action of one-carbon pathway and associated metabo-
lites including folate, riboflavin, choline and betaine
[14]. Multiple studies, including follow-ups to rando-
mised controlled trials with maternal folate in-
terventions, have looked at the effect of folate in
pregnancy on offspring DNA methylation [38e41].
These have found many positive associations, but with
no consistent pattern of associated genes or effect di-
rection emerging, although this may be due to variation
in windows of exposure and differences in times of
measurement in postnatal tissues.
Other evidence comes from so-called ‘natural experi-
ments’ such as the DHW studies. From a fetal pro-
gramming perspective, a notable DHW study of 885
subjects found evidence that a number of methylation
loci measured in whole blood mediated a relationship
between exposure to maternal famine in utero and adult
BMI and serum triglycerides, including at genes related
to glycolysis and adipogenesis, with methylation-
associated gene expression changes in an external data
set [42]. A series of studies in The Gambia in sub-
Saharan West Africa exploited another natural experi-
ment, whereby a population largely dependent on sub-
sistence farming experiences annual patterns of rainy
and dry seasons, with corresponding significant seasonal
differences in one-carbon nutrients measured in
maternal plasma. These studies have found DNA
methylation changes associated with season of concep-
tion and certain one-carbon nutrients at human meta-
stable epialleles d loci with independent evidence of
establishment in the early embryo [43,44]. Notably,
methylation at one region within the POMC gene with
evidence of nutrient-sensitive establishment in the
early embryo and altered methylation in the arcuate
nucleus of the hypothalamus has been associated with
obesity in German children and adults [45,46].
Maternal smoking
Multiple studies have identified consistent changes at
specific methylation loci measured in offspring blood
that are associated with maternal smoking duringCurrent Opinion in Endocrine and Metabolic Research 2020, 13:1–6
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netic biomarkers of an early environmental exposure.
Large studies reveal that smoking-associated changes
are present at birth in cord blood and appear to persist at
least into adolescence [47,48]. More recently, a series of
studies have used causal analysis techniques such as
Mendelian randomisation to explore links to health
outcomes and related traits in offspring. A meta-analysis
of five prospective birth cohorts with participant ages
ranging from 16 to 48 years identified several loci
measured in blood that were associated with maternal
pregnancy in smoking, with evidence of a causal link to
increased risk of inflammatory bowel disease and psy-
chiatric morbidity in offspring [49]. Another study
linked smoking-related loci identified in a previous
meta-analysis to reduced lung function, with evidence
that this effect was mediated by changes in gene
expression [50]. Finally, a recent study of 995 Australian
adolescents from the Raine cohort identified methyl-
ation loci in blood linked to prenatal smoking that were
associated with several cardiovascular risk factors [51].Challenges, opportunities and avenues for
future research
Establishing an epigenetically mediated causal pathway
from exposure through to disease in human cohorts is
challenging. Analyses are prone to confounding, and in
contrast to genetic associations studies, epigenetic
changes may be driven by reverse causation effects,
where a disease or trait causes changes in the epigenome.
A deeper understanding of links between early-life ex-
posures and health outcomes therefore requires careful
appraisal of existing evidence. Diverse study designs
including the use of longitudinal cohorts, negative con-
trols and in the case of analysis of modifiable exposures,
randomised controlled trials are warranted, along with
other techniques for strengthening causal inference such
as Mendelian randomisation [52].
Furthermore, epigenetic assays have their own biases
and limitations. For example, genome-wide DNA
methylation arrays used in most human cohort studies
cover a small fraction of the human methylome. They
are often designed to focus on specific functional ele-
ments such as gene promoters and enhancers, so that
potentially important signals, for example, in intergenic
regions, will be missed. Unbiased approaches such as
whole-genome bisulfite sequencing are currently pro-
hibitively expensive for population studies. Methylation
array-based assays are also prone to systematic errors
arising from their design. These must be accounted for
during statistical analysis, along with potential
confounding due to tissue- and cell-specific methylation
patterns in heterogenous samples [15].
Genetic variation also has a strong influence on the
epigenome so that an understanding of the interplayCurrent Opinion in Endocrine and Metabolic Research 2020, 13:1–6between genotype, epigenotype and environment in
genetically heterogenous human populations is required
to fully elucidate drivers of fetal programming effects,
alongside functional work in animal and cell models that
now forms an important component of work in molecular
epidemiology.
It is also important to note that the majority of human
methylation studies are conducted in European and
North American populations, limiting power to detect
ethnic differences in fetal programming effects, and few
studies consider sex interactions, despite evidence that
sexual dimorphism may in some cases be epigenetically
regulated [53].
Epigenetic association studies are increasingly benefit-
ting from techniques such as ATAC-seq and ChIP-seq
that can link observed methylation changes to func-
tional outcomes at the molecular level, and from access
to public bioinformatic resources mapping tissue-
specific chromatin accessibility and gene expression
patterns [54,55].
Despite the many challenges, robust exposure-
methylation associations have potentially been used as
biomarkers of exposure in research studies and clinical
medicine. Epigenetic signatures could be used in
epidemiological studies as a quantitative biomarker of
exposure, improving our understanding of the role of
geneeenvironment interactions in disease risk [56].
Epigenetic signatures could also be used to guide
personalised preventative medicine strategies in in-
dividuals and whole populations [57,58].
In addition, some groups are investigating the potential
to mitigate or prevent adverse epigenetic changes
during pregnancy through nutritional supplements or
parenting and bonding support interventions [59,60].
This concept is most advanced in the context of cancer
therapies, where agents such as inhibitors of DNA
methyltransferase and histone deacetylase are being
used to slow the progression of tumours and aberrant
haematopoiesis [61]. It is possible that some of these
techniques could one day be applied to mitigate or
reverse adverse effects of fetal programming, although
correction of suboptimal developmental trajectories that
are already set in early life may not be amenable to
postnatal therapies.Conclusion
Epidemiological evidence strongly supports the notion
that adverse prenatal exposures can have negative con-
sequences for life-long health through fetal program-
ming. There is mounting evidence that some of these
effects are mediated by environmentally driven changes
to the epigenome, with early gestation emerging as a
particular window of sensitivity.www.sciencedirect.com
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